Medtronic/MiniMed Insulin Pump Paradigm Aims To Grow 80% Market Share
This article was originally published in The Gray Sheet
Executive Summary
Medtronic/MiniMed expects to boost its 80% share of the U.S. diabetes pump market with the Paradigm Model 511 insulin infusion system. A full-scale U.S. launch was announced Feb. 18